This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) slipped 7.14% to $127.90 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.76% to 11,535.02 and the Dow Jones Industrial Average rising 0.64% to 31,019.68. Moderna Inc. closed $330.60 below its 52-week high ($458.50), which the company achieved on September 23rd.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.97% to $142.66, Amgen Inc. (AMGN) fell 0.16% to $230.76, and AstraZeneca PLC ADR (AZN.LN) fell 0.10% to $57.99. Trading volume (11.4 M) eclipsed its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 19, 2022.
(END) Dow Jones Newswires
September 19, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.